Print Issue: December 01, 2011

Ductal delivery of breast drugs may best IV

Compared to standard chemotherapy, administering cancer-fighting agents directly into breast ducts rather than intravenously may be safer and less painful for controlling early breast cancer.

FDA Update: December 2011

In November and December 2011, the FDA approved a number of new cancer drugs. Highlights include cetuximab for head and neck cancer, Hemacord, and asparaginase Erwinia chrysanthemi for ALL.

Next post in In the News